Epidemiology and Pathogenesis of Aspiration Pneumonia

Abstract

Aspiration pneumonia (AP) remains a critical health issue, especially among older and hospitalized patients. This review focuses on understanding the epidemiology and pathogenesis of AP, exploring key risk factors, and proposing diagnostic strategies. Aspiration pneumonia is commonly associated with hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), where pathogens introduced into the lungs from gastric aspiration cause infection. Several factors, such as oropharyngeal dysphagia, silent aspiration, and poor oral health, contribute to increased risk, especially in frail elderly populations with chronic comorbidities. Diagnostic criteria for AP are not well-defined, complicating accurate diagnosis. Radiographic evidence of pulmonary infiltrates, history of aspiration, and clinical symptoms, such as cough and fever, guide diagnosis, but the absence of specific biomarkers remains a challenge. Furthermore, the microbiome of the lung, which shares characteristics with the oropharyngeal flora, plays a pivotal role in the development of infection. The incidence of AP is likely to increase given the growing elderly population with factors predisposing them to aspiration. It is one of the most common types of pneumonia in older adults, with its prevalence estimated to range from 5% to 24% in cases of CAP admissions. This revision highlights the growing need for comprehensive diagnostic tools and treatment protocols for AP, especially in high-risk populations such as the elderly and those in long-term care. Understanding the underlying mechanisms and the role of silent aspiration can improve prevention strategies and reduce morbidity and mortality in these vulnerable groups.

Keywords

pneumonia - aspiration pneumonia - CAP - HAP

• References

• 1 Smithard DG, Yoshimatsu Y. Pneumonia, aspiration pneumonia, or frailty-associated pneumonia?. Geriatrics (Basel) 2022; 7 (05) 115
• 2 Almirall J, Boixeda R, de la Torre MC, Torres A. Aspiration pneumonia: a renewed perspective and practical approach. Respir Med 2021; 185: 106485
• 3 Mason CM, Nelson S. Pulmonary host defenses and factors predisposing to lung infection. Clin Chest Med 2005; 26 (01) 11-17
• 4 Kikawada M, Iwamoto T, Takasaki M. Aspiration and infection in the elderly : epidemiology, diagnosis and management. Drugs Aging 2005; 22 (02) 115-130
• 5 Feldman C, Anderson R. Community-acquired pneumonia: still a major burden of disease. Curr Opin Crit Care 2016; 22 (05) 477-484
• 6 Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003; 124 (01) 328-336
• 7 Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11 (04) 586-599
• 8 Mylotte JM. Nursing home-acquired pneumonia. Clin Infect Dis 2002; 35 (10) 1205-1211
• 9 Rotta AT, Shiley KT, Davidson BA, Helinski JD, Russo TA, Knight PR. Gastric acid and particulate aspiration injury inhibits pulmonary bacterial clearance. Crit Care Med 2004; 32 (03) 747-754
• 10 El-Solh AA, Vora H, Knight III PR, Porhomayon J. Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes. Crit Care Med 2011; 39 (06) 1251-1256
• 11 Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest 1997; 111 (05) 1266-1272
• 12 Almirall J, Serra-Prat M, Bolíbar I, Balasso V. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration 2017; 94 (03) 299-311
• 13 Almirall J, Rofes L, Serra-Prat M. et al. Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J 2013; 41 (04) 923-928
• 14 Almirall J, Bolíbar I, Balanzó X, González CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 1999; 13 (02) 349-355
• 15 Komiya K, Rubin BK, Kadota JI. et al. Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: a systematic review with meta-analysis. Sci Rep 2016; 6: 38097
• 16 Segal LN, Rom WN, Weiden MD. Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 2014; 11 (01) 108-116
• 17 de Steenhuijsen Piters WA, Huijskens EG, Wyllie AL. et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J 2016; 10 (01) 97-108
• 18 Mandell LA, Niederman MS. Aspiration Pneumonia. N Engl J Med 2019; 380 (07) 651-663
• 19 Rodriguez F, Bolibar I, Serra-Prat M, Palomera E, Ballester MV, Almirall J. Poor oral health is a risk factor for community-acquired pneumonia. J Pulm Respir Med 2014; 4: 203-208
• 20 Almirall J, Bolíbar I, Vidal J. et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15 (04) 757-763
• 21 El-Solh AA, Pietrantoni C, Bhat A. et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167 (12) 1650-1654
• 22 Aspiration pneumonitis and pneumonia: a critical review. N Engl J Med 2001; 344 (09) 665-672
• 23 Cabre M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 2010; 39 (01) 39-45
• 24 Terré-Boliart R, Orient-López F, Guevara-Espinosa D, Ramón-Rona S, Bernabeu-Guitart M, Clavé-Civit P. [Oropharyngeal dysphagia in patients with multiple sclerosis [in Spanish]. Rev Neurol 2004; 39 (08) 707-710